Modular Medical (MODD) EBITDA (2011 - 2026)

Modular Medical (MODD) has reported EBITDA for 10 consecutive years, with -$6.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA rose 3.91% year-over-year to -$6.5 million; the trailing twelve-month figure through Jun 2026 stood at -$27.3 million (down 26.17% YoY), and the FY2026 full-year result was -$27.6 million, down 44.69% from the prior year.
• EBITDA fell to -$6.5 million in Q2 2026 per MODD's latest filing, from -$5.7 million in the prior quarter.
• Across five years, EBITDA topped out at -$3.4 million in Q4 2022 and bottomed at -$7.8 million in Q3 2025.
• Historically, EBITDA has averaged -$4.9 million across 5 years, with a median of -$4.6 million in 2024.
• The widest YoY moves for EBITDA: up 12.35% in 2022, down 132.42% in 2022.
• Over 5 years, EBITDA stood at -$3.4 million in 2022, then tumbled by 56.91% to -$5.3 million in 2023, then increased by 7.88% to -$4.9 million in 2024, then tumbled by 49.24% to -$7.2 million in 2025, then gained by 9.75% to -$6.5 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$6.5 million, -$5.7 million, and -$7.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.